ArticleJournal of Cancer2020

Anti-tumor Activity of Bufalin by Inhibiting c-MET Mediated MEK/ERK and PI3K/AKT Signaling Pathways in Gallbladder Cancer.

Liqiang Qian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.